Small Molecule Outsourcing STREAM

  1. Expanding The OSD Toolbox 10/3/2024

    This session is designed to provide practical solutions for enhancing bioavailability and scalability in pharmaceutical formulations.

  2. Small Molecule APIs: From Pre-RSM To Final API 8/31/2023

    As a leader in small molecule manufacturing, Ajinomoto Bio-Pharma Services has over 40 years of experience providing high quality APIs and intermediates for pharmaceutical companies throughout the world.

  3. Patient- And Planet-Centric Bioavailability And Sustained Delivery

    By reducing the size of drug particles, nanoforming offers new opportunities — from increased bioavailability to sustained drug delivery. Discover the potential benefits supported by case studies.

  4. Cambrex Scientist Spotlight: Myoung Goo Kim 1/29/2025

    Myoung Goo Kim, Chemistry R&D Manager in High Point, NC, is a recognized expert in process chemistry, specializing in API manufacturing for Cambrex’s clients.

  5. The Paradigm Shift To Continuous Flow Processes: A Holistic View

    A clear increase in continuous flow processes has emerged over the past decade, thanks to the commercialization of preparative flow reactor units.

  6. Scaling Up A Revolutionary Amorphous Solid Dispersion Platform 3/19/2024

    Process parameter and quality attribute relationships, including those for typical pre- and post-ASD unit operations, will be explored in the context of real-world examples.

  7. How Can Nanoparticle Engineering Make The Difference For Alzheimer's? 4/9/2023

    Commercial Insights Officer Jamie Unwin discusses the power of innovative nanoparticle engineering technology and AI-based digital twin.

  8. Improve The Performance Of Your Small And Large Molecule Medicines 7/23/2024

    Explore the latest in nanotechnology advancements including recent clinical data, formulation applications, and API optimization to NanoImprove formulations.

  9. Taste Masking 101: Sensory And Performance Evaluation 7/11/2022

    Learn how techniques and innovations in taste masking sensory and performance evaluation can help accelerate your formulation development and confirm desired taste profile.

  10. Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders

    Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.